The results of immunohistochemistry (IHC) staining revealed that Gal‐SLPs efficiently suppressed the expression of Ki67, a marker for tumor proliferation, further confirming the excellent antitumor capability of Gal‐SLP. The gene discussed is MKI67; the disease is neoplasm.